{"results": [{"id": "0001369568:2011:FY", "start_date": "2011-01-01", "end_date": "2011-12-31", "filing_date": "2012-03-30", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2011", "cik": "0001369568", "sic": "2834", "tickers": ["CPRX"], "company_name": "CATALYST PHARMACEUTICAL PARTNERS, INC.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-12-143728", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-12-143728/files/cprx-20111231.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -6391062.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -6391062.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "income_statement": {"participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_before_equity_method_investments": {"value": -6391062.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_expenses": {"value": 6082139.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss": {"value": -6391062.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_parent": {"value": -6391062.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_income_loss": {"value": -6082139.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -6391062.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_before_tax": {"value": -6391062.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_from_continuing_operations_after_tax": {"value": -6391062.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}, "cash_flow_statement": {"net_cash_flow": {"value": 553909, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -4985049.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 5542578.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -4985049.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -3620, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": 553909, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": -3620, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 5542578.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}, "balance_sheet": {"current_liabilities": {"value": 833801, "unit": "USD", "label": "Current Liabilities", "order": 700}, "fixed_assets": {"value": 12186, "unit": "USD", "label": "Fixed Assets", "order": 400}, "liabilities": {"value": 2488559.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 21074, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities_and_equity": {"value": 6249257.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_than_fixed_noncurrent_assets": {"value": 8888, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "current_assets": {"value": 6228183.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 6249257.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 1654758.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": 3760698.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": 3760698.0, "unit": "USD", "label": "Equity", "order": 1400}}}}, {"id": "0001369568:2012:FY", "start_date": "2012-01-01", "end_date": "2012-12-31", "filing_date": "2013-04-01", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2012", "cik": "0001369568", "sic": "2834", "tickers": ["CPRX"], "company_name": "CATALYST PHARMACEUTICAL PARTNERS, INC.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-13-136777", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-13-136777/files/cprx-20121231.xml", "financials": {"income_statement": {"preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 5221140.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "operating_income_loss": {"value": -5221140.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_parent": {"value": -4076386.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss": {"value": -4076386.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_after_tax": {"value": -4076386.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_before_equity_method_investments": {"value": -4076386.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "income_loss_from_continuing_operations_before_tax": {"value": -4076386.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -4076386.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}}, "balance_sheet": {"other_than_fixed_noncurrent_assets": {"value": 8888, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "current_assets": {"value": 16726678.0, "unit": "USD", "label": "Current Assets", "order": 200}, "fixed_assets": {"value": 53679, "unit": "USD", "label": "Fixed Assets", "order": 400}, "liabilities": {"value": 2167130.0, "unit": "USD", "label": "Liabilities", "order": 600}, "liabilities_and_equity": {"value": 16789245.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_parent": {"value": 14622115.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 62567, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 520465, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity": {"value": 14622115.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 1646665.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 16789245.0, "unit": "USD", "label": "Assets", "order": 100}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -4076386.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -4076386.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": -14059651.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": -4619128.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 14580889.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": 14580889.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": -4619128.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -5140366.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -5140366.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": -14059651.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}}}, {"id": "0001369568:2013:FY", "start_date": "2013-01-01", "end_date": "2013-12-31", "filing_date": "2014-03-19", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2013", "cik": "0001369568", "sic": "2834", "tickers": ["CPRX"], "company_name": "CATALYST PHARMACEUTICAL PARTNERS, INC.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-14-104658", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-14-104658/files/cprx-20131231.xml", "financials": {"income_statement": {"preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss": {"value": -12154596.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -12154596.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -12154596.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_income_loss": {"value": -10311658.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "operating_expenses": {"value": 10311658.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": -12154596.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_before_equity_method_investments": {"value": -12154596.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_parent": {"value": -12154596.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -12154596.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -12154596.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 18178494.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": -7496801.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 18178494.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -9875674.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -9875674.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -7496801.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": 806019, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": 806019, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "balance_sheet": {"liabilities": {"value": 3978302.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity": {"value": 21391252.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_liabilities": {"value": 1838693.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 40628, "unit": "USD", "label": "Fixed Assets", "order": 400}, "other_than_fixed_noncurrent_assets": {"value": 8888, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 25369554.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_assets": {"value": 49516, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": 21391252.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities_and_equity": {"value": 25369554.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 2139609.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "current_assets": {"value": 25320038.0, "unit": "USD", "label": "Current Assets", "order": 200}}}}, {"id": "0001369568:2014:FY", "start_date": "2014-01-01", "end_date": "2014-12-31", "filing_date": "2015-03-13", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2014", "cik": "0001369568", "sic": "2834", "tickers": ["CPRX"], "company_name": "CATALYST PHARMACEUTICAL PARTNERS, INC.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-15-091323", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-15-091323/files/cprx-20141231.xml", "financials": {"balance_sheet": {"current_assets": {"value": 43827821.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_parent": {"value": 35242330.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 2810730.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 8665756.0, "unit": "USD", "label": "Liabilities", "order": 600}, "assets": {"value": 43908086.0, "unit": "USD", "label": "Assets", "order": 100}, "other_than_fixed_noncurrent_assets": {"value": 8888, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "equity": {"value": 35242330.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 5855026.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 43908086.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "fixed_assets": {"value": 71377, "unit": "USD", "label": "Fixed Assets", "order": 400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 80265, "unit": "USD", "label": "Noncurrent Assets", "order": 300}}, "income_statement": {"income_loss_before_equity_method_investments": {"value": -15509061.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "income_loss_from_continuing_operations_after_tax": {"value": -15509061.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": -15509061.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_expenses": {"value": 14591428.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_available_to_common_stockholders_basic": {"value": -15509061.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss": {"value": -15509061.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_income_loss": {"value": -14591428.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_parent": {"value": -15509061.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -15509061.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -15509061.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 28563633.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": -8741030.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 28563633.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -12941783.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -12941783.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 6880820.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": -8741030.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 6880820.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}}}, {"id": "0001369568:2015:FY", "start_date": "2015-01-01", "end_date": "2015-12-31", "filing_date": "2016-03-15", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2015", "cik": "0001369568", "sic": "2834", "tickers": ["CPRX"], "company_name": "CATALYST PHARMACEUTICALS, INC.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-16-505167", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-16-505167/files/cprx-20151231.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 37159958.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": 19138238.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": -6499, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -18015221.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 37159958.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -6499, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -18015221.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": 19138238.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "balance_sheet": {"fixed_assets": {"value": 191549, "unit": "USD", "label": "Fixed Assets", "order": 400}, "liabilities_and_equity": {"value": 60101570.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": 4625259.0, "unit": "USD", "label": "Liabilities", "order": 600}, "assets": {"value": 60101570.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 1184656.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_assets": {"value": 59901133.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": 55476311.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 3440603.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_than_fixed_noncurrent_assets": {"value": 8888, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "equity_attributable_to_parent": {"value": 55476311.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 200437, "unit": "USD", "label": "Noncurrent Assets", "order": 300}}, "income_statement": {"revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_expenses": {"value": 20398352.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_after_tax": {"value": -20232958.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -20232958.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": -20232958.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_income_loss": {"value": -20398352.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_parent": {"value": -20232958.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_before_tax": {"value": -20232958.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -20232958.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -20232958.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}}}, {"id": "0001369568:2016:FY", "start_date": "2016-01-01", "end_date": "2016-12-31", "filing_date": "2017-03-15", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2016", "cik": "0001369568", "sic": "2834", "tickers": ["CPRX"], "company_name": "CATALYST PHARMACEUTICALS, INC.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-17-083667", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-17-083667/files/cprx-20161231.xml", "financials": {"income_statement": {"net_income_loss_available_to_common_stockholders_basic": {"value": -18072452.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_before_tax": {"value": -18072452.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_from_continuing_operations_after_tax": {"value": -18072452.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_expenses": {"value": 19280201.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss": {"value": -18072452.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_parent": {"value": -18072452.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_income_loss": {"value": -19280201.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -18072452.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -18072452.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -17963503.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": -14341952.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -17963503.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 68986, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": -14341952.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": 3552565.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 3552565.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 68986, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}, "balance_sheet": {"noncurrent_assets": {"value": 253092, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": 39308930.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities_and_equity": {"value": 41706853.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "assets": {"value": 41706853.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 2094535.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "current_assets": {"value": 41453761.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 303388, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 244204, "unit": "USD", "label": "Fixed Assets", "order": 400}, "equity": {"value": 39308930.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 2397923.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_than_fixed_noncurrent_assets": {"value": 8888, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}}}}, {"id": "0001369568:2017:FY", "start_date": "2017-01-01", "end_date": "2017-12-31", "filing_date": "2018-03-14", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2017", "cik": "0001369568", "sic": "2834", "tickers": ["CPRX"], "company_name": "CATALYST PHARMACEUTICALS, INC.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-18-082292", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-18-082292/files/cprx-20171231.xml", "financials": {"income_statement": {"net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_attributable_to_parent": {"value": -18412377.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -18679636.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_before_tax": {"value": -18412377.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -18412377.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_after_tax": {"value": -18412377.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_expenses": {"value": 18679636.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss": {"value": -18412377.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -13742572.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 57350168.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 43603638.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": 43603638.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": -3958, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 57350168.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": -3958, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -13742572.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "balance_sheet": {"current_assets": {"value": 85187157.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity": {"value": 80963812.0, "unit": "USD", "label": "Equity", "order": 1400}, "assets": {"value": 85387430.0, "unit": "USD", "label": "Assets", "order": 100}, "fixed_assets": {"value": 191385, "unit": "USD", "label": "Fixed Assets", "order": 400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 157456, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 4423618.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": 80963812.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 4266162.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_assets": {"value": 200273, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_than_fixed_noncurrent_assets": {"value": 8888, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "liabilities_and_equity": {"value": 85387430.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -18412377.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -18412377.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}}}, {"id": "0001369568:2018:FY", "start_date": "2018-01-01", "end_date": "2018-12-31", "filing_date": "2019-03-18", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2018", "cik": "0001369568", "sic": "2834", "tickers": ["CPRX"], "company_name": "CATALYST PHARMACEUTICALS, INC.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-19-078253", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-19-078253/files/cprx-20181231.xml", "financials": {"income_statement": {"income_loss_from_continuing_operations_before_tax": {"value": -34003514.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_parent": {"value": -34003514.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_after_tax": {"value": -34003514.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss": {"value": -34003514.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_expenses": {"value": 35795165.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_available_to_common_stockholders_basic": {"value": -34003514.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "revenues": {"value": 500000, "unit": "USD", "label": "Revenues", "order": 100}, "operating_income_loss": {"value": -35295165.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "costs_and_expenses": {"value": 34503514.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "benefits_costs_expenses": {"value": 34503514.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -25704406.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -40937302.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": -40937302.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 293115, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -15526011.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -25704406.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 293115, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": -15526011.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "balance_sheet": {"liabilities": {"value": 9666153.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_liabilities": {"value": 9511354.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_assets": {"value": 5262556.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 154799, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 60449962.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_than_fixed_noncurrent_assets": {"value": 5017131.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "current_assets": {"value": 55187406.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 50783809.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "fixed_assets": {"value": 245425, "unit": "USD", "label": "Fixed Assets", "order": 400}, "equity": {"value": 50783809.0, "unit": "USD", "label": "Equity", "order": 1400}, "assets": {"value": 60449962.0, "unit": "USD", "label": "Assets", "order": 100}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -34023762.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -34023762.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -20248, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}}}, {"id": "0001369568:2019:FY", "start_date": "2019-01-01", "end_date": "2019-12-31", "filing_date": "2020-03-16", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2019", "cik": "0001369568", "sic": "2834", "tickers": ["CPRX"], "company_name": "CATALYST PHARMACEUTICALS, INC.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-20-075048", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-20-075048/files/cprx-20191231.xml", "financials": {"balance_sheet": {"fixed_assets": {"value": 210467, "unit": "USD", "label": "Fixed Assets", "order": 400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 1012607.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 647532, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_assets": {"value": 111363623.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_than_fixed_noncurrent_assets": {"value": 802140, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "assets": {"value": 112376230.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_parent": {"value": 87629956.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities": {"value": 24746274.0, "unit": "USD", "label": "Liabilities", "order": 600}, "liabilities_and_equity": {"value": 112376230.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 24098742.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": 87629956.0, "unit": "USD", "label": "Equity", "order": 1400}}, "income_statement": {"income_tax_expense_benefit": {"value": 1533696.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_attributable_to_parent": {"value": 31875337.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_before_tax": {"value": 33409033.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "cost_of_revenue": {"value": 14759139.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": 31823259.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": 31875337.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "benefits_costs_expenses": {"value": 68897304.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "revenues": {"value": 102306337.0, "unit": "USD", "label": "Revenues", "order": 100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "gross_profit": {"value": 87547198.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "income_tax_expense_benefit_deferred": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit, Deferred", "order": 2400}, "net_income_loss": {"value": 31875337.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_tax_expense_benefit_current": {"value": 1533696.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Current", "order": 2300}, "basic_earnings_per_share": {"value": 0.31, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "costs_and_expenses": {"value": 68897304.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_available_to_common_stockholders_basic": {"value": 31875337.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "diluted_earnings_per_share": {"value": 0.3, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "operating_expenses": {"value": 55723939.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": 31905090.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": 31905090.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 29753, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 1116242.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 72952310.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": 72952310.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": 34611473.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": 34611473.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 1116242.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": 37224595.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": 37224595.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}}}, {"id": "0001369568:2020:FY", "start_date": "2020-01-01", "end_date": "2020-12-31", "filing_date": "2021-03-15", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2020", "cik": "0001369568", "sic": "2834", "tickers": ["CPRX"], "company_name": "CATALYST PHARMACEUTICALS, INC.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-21-081545", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-21-081545/files/d29693d10k_htm.xml", "financials": {"income_statement": {"net_income_loss_attributable_to_parent": {"value": 74983000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_tax_expense_benefit_current": {"value": -121662, "unit": "USD", "label": "Income Tax Expense/Benefit, Current", "order": 2300}, "revenues": {"value": 119072803.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_tax_expense_benefit_deferred": {"value": -32971264.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Deferred", "order": 2400}, "income_loss_from_continuing_operations_before_tax": {"value": 41890074.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_earnings_per_share": {"value": 0.72, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss": {"value": 74983000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "costs_and_expenses": {"value": 77182729.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": 41303177.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "cost_of_revenue": {"value": 17039157.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "operating_expenses": {"value": 60730469.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_after_tax": {"value": 74983000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_tax_expense_benefit": {"value": -33092926.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "diluted_earnings_per_share": {"value": 0.71, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_available_to_common_stockholders_basic": {"value": 74983000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "gross_profit": {"value": 102033646.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "benefits_costs_expenses": {"value": 77182729.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": 75004827.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": 75004827.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 21827, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": 45034864.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 40725399.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": -5011398.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 40725399.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": 45034864.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 701933, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": -5011398.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 701933, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}, "balance_sheet": {"noncurrent_assets": {"value": 33109952.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_liabilities": {"value": 22756287.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 192353926.0, "unit": "USD", "label": "Assets", "order": 100}, "current_assets": {"value": 159243974.0, "unit": "USD", "label": "Current Assets", "order": 200}, "fixed_assets": {"value": 129800, "unit": "USD", "label": "Fixed Assets", "order": 400}, "other_than_fixed_noncurrent_assets": {"value": 32980152.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": 169597639.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": 169597639.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities_and_equity": {"value": 192353926.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": 22756287.0, "unit": "USD", "label": "Liabilities", "order": 600}}}}, {"id": "0001369568:2021:FY", "start_date": "2021-01-01", "end_date": "2021-12-31", "filing_date": "2022-03-16", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2021", "cik": "0001369568", "sic": "2834", "tickers": ["CPRX"], "company_name": "CATALYST PHARMACEUTICALS, INC.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-22-077228", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-22-077228/files/d159262d10k_htm.xml", "financials": {"balance_sheet": {"assets": {"value": 237788000.0, "unit": "USD", "label": "Assets", "order": 100}, "fixed_assets": {"value": 959000, "unit": "USD", "label": "Fixed Assets", "order": 400}, "noncurrent_liabilities": {"value": 3894000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_than_fixed_noncurrent_assets": {"value": 26723000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "equity": {"value": 206831000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 30957000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 210106000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 27682000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities_and_equity": {"value": 237788000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_parent": {"value": 206831000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 27063000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": 39303000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -179000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": 39303000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": 60372000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": 60372000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": -8143000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": -8143000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -11021000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": 41208000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": -11021000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": 41208000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "income_statement": {"benefits_costs_expenses": {"value": 88166000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "costs_and_expenses": {"value": 88166000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "cost_of_revenue": {"value": 21884000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "revenues": {"value": 140833000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_available_to_common_stockholders_basic": {"value": 39482000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_before_tax": {"value": 52667000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "diluted_earnings_per_share": {"value": 0.37, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_attributable_to_parent": {"value": 39482000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_tax_expense_benefit": {"value": 13185000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "gross_profit": {"value": 118949000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "operating_expenses": {"value": 66564000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss": {"value": 39482000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "basic_earnings_per_share": {"value": 0.38, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_income_loss": {"value": 52385000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_tax_expense_benefit_current": {"value": 3869000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Current", "order": 2300}, "income_tax_expense_benefit_deferred": {"value": 9316000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Deferred", "order": 2400}, "income_loss_from_continuing_operations_after_tax": {"value": 39482000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}}}}], "status": "OK", "request_id": "02820ae47a8f5488c1fcad2baa04c9f7"}